Immune response pattern in recurrent Plasmodium vivax malaria

被引:27
|
作者
Chaves, Yury Oliveira [1 ]
da Costa, Allyson Guimaraes [2 ,3 ,4 ]
Monteiro Pereira, Marcelo Luis [5 ]
Guimaraes de Lacerda, Marcus Vinicius [1 ,2 ,3 ]
Coelho-dos-Reis, Jordana Grazziela [6 ]
Martins-Filho, Olindo Assis [6 ]
Teixeira-Carvalho, Andrea [6 ]
Malheiro, Adriana [4 ,7 ]
Monteiro, Wuelton Marcelo [2 ,3 ]
Orlandi, Patricia Puccinelli [1 ]
Farias Marinho, Claudio Romero [5 ]
Nogueira, Paulo Afonso [1 ]
机构
[1] Fundacao Oswaldo Cruz FIOCRUZ, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil
[2] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil
[3] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil
[4] Fundacao Hosp Hematol & Hemoterapia Amazonas HFMO, Dept Ensino & Pesquisa, Manaus, Amazonas, Brazil
[5] Univ Sao Paulo, Inst Ciencias Biol, Dept Parasitol, Sao Paulo, SP, Brazil
[6] Fundacao Oswaldo Cruz FIOCRUZ, Grp Integrado Pesquisas Biomarcadores Diagnost &, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil
[7] Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil
来源
MALARIA JOURNAL | 2016年 / 15卷
关键词
Malaria; Recurrence; Plasmodium vivax; Interleukin-10; CD4(+) T-cells; CD8(+) T-cells; TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; DIHYDROARTEMISININ-PIPERAQUINE; FALCIPARUM-MALARIA; LYMPHOCYTE SUBSETS; PERIPHERAL-BLOOD; CHILDREN; INFECTION; IL-10; RELAPSES;
D O I
10.1186/s12936-016-1501-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Plasmodium vivax is the causative agent of human malaria of large geographic distribution, with 35 million cases annually. In Brazil, it is the most prevalent species, being responsible by around 70 % of the malaria cases. Methods: A cross-sectional study was performed in Manaus (Amazonas, Brazil), including 36 adult patients with primary malaria, 19 with recurrent malaria, and 20 endemic controls. The ex vivo phenotypic features of circulating leukocyte subsets (CD4(+) T-cells, CD8(+) T-cells, NK, NKT, B, B1 and Treg cells) as well as the plasmatic cytokine profile (IL-2, IL-4, IL-6, IL-10, TNF and IFN-gamma) were assessed, aiming at establishing patterns of immune response characteristic of primary malaria vs recurrent malaria as compared to endemic controls. Results: The proportion of subjects with high levels of WBC was reduced in malaria patients as compared to the endemic control. Monocytes were diminished particularly in patients with primary malaria. The proportion of subjects with high levels of all lymphocyte subsets was decreased in all malaria groups, regardless their clinical status. Decreased proportion of subjects with high levels of CD4(+) and CD8(+) T-cells was found especially in the group of patients with recurrent malaria. Data analysis indicated significant increase in the proportion of the subjects with high plasmatic cytokine levels in both malaria groups, characterizing a typical cytokine storm. Recurrent malaria patients displayed the highest plasmatic IL-10 levels, that correlated directly with the CD4(+)/CD8(+) T-cells ratio and the number of malaria episodes. Conclusion: The findings confirm that the infection by the P. vivax causes a decrease in peripheral blood lymphocyte subsets, which is intensified in the cases of "recurrent malaria". The unbalanced CD4(+)/CD8(+) T-cells ratio, as well as increased IL-10 levels were correlated with the number of recurrent malaria episodes. These results suggest that the gradual remodelling of the immune response is dependent on the repeated exposure to the parasite, which involves a strict control of the immune response mediated by the CD4(+)/CD8+ T-cell unbalance and exacerbated IL-10 secretion.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
    Stephen D. Woolley
    Louise Marquart
    John Woodford
    Stephan Chalon
    Joerg J. Moehrle
    James S. McCarthy
    Bridget E. Barber
    Malaria Journal, 20
  • [22] Facial Diplegia in Plasmodium vivax Malaria
    Sim, Jae Eun
    Choi, Young-Chul
    Kim, Won-Joo
    JOURNAL OF CLINICAL NEUROLOGY, 2010, 6 (02): : 102 - 103
  • [23] Thrombocytopenia in Plasmodium vivax Malaria Is Related to Platelets Phagocytosis
    Coelho, Helena Cristina C.
    Lopes, Stefanie C. P.
    Pimentel, Joao Paulo D.
    Nogueira, Paulo A.
    Costa, Fabio T. M.
    Siqueira, Andre M.
    Melo, Gisely C.
    Monteiro, Wuelton M.
    Malheiro, Adriana
    Lacerda, Marcus V. G.
    PLOS ONE, 2013, 8 (05):
  • [24] Diagnosis and Treatment of Plasmodium vivax Malaria
    Baird, J. Kevin
    Maguire, Jason D.
    Price, Ric N.
    ADVANCES IN PARASITOLOGY, VOL 80: EPIDEMIOLOGY OF PLASMODIUM VIVAX: HISTORY, HIATUS AND HUBRIS, PT A, 2012, 80 : 203 - 270
  • [25] A mixed malaria infection: is Plasmodium vivax good for you?
    Whitehorn, J.
    Coltart, C.
    Manser, D.
    Doherty, T.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2010, 104 (03) : 240 - 241
  • [26] THROMBOCYTOPENIA IN RELATION WITH PLASMODIUM VIVAX MALARIA
    Vaidya, K. Kuladeepa Ananda
    Vernekar, Pradeep
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2012, 1 (04): : 413 - 417
  • [27] Management of relapsing Plasmodium vivax malaria
    Chu, Cindy S.
    White, Nicholas J.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (10) : 885 - 900
  • [28] The prevention and treatment of Plasmodium vivax malaria
    Chu, Cindy S.
    White, Nicholas J.
    PLOS MEDICINE, 2021, 18 (04)
  • [29] Alternative Invasion Mechanisms and Host Immune Response to Plasmodium vivax Malaria: Trends and Future Directions
    Kepple, Daniel
    Pestana, Kareen
    Tomida, Junya
    Abebe, Abnet
    Golassa, Lemu
    Lo, Eugenia
    MICROORGANISMS, 2021, 9 (01) : 1 - 17
  • [30] New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
    Price, Ric N.
    Douglas, Nicholas M.
    Anstey, Nicholas M.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (05) : 430 - 435